Rentabilitas dodolan miturut bathi resik: ARS Pharmaceuticals Inc (SPRY)

Tandha merek ARS Pharmaceuticals, Inc. (SPRY)

The development of the neffy needle-free spray and its regulatory approval created a powerful growth impulse reflected in the net profitability chart from GURU.Markets, where the current value is -163.60. However, risks of registration delays and insurance complexities are constraining the momentum. Meanwhile, the product's unique format ensures leadership for ARS Pharmaceuticals (SPRY), minimizing price wars with competitors.

Margin bathi resik ARS Corp (SPRY): kanggo periode 28.04.2023 - 19.11.2026

SPRY (ARS Corp): rincian analitis lan laporan miturut indikator

- nilai pasar lan prakiraan target analis:
Ringkesan analitik perusahaan:ARS Pharmaceuticals
Barang unggulan ARS Pharma

ARS Pharmaceuticals (SPRY) maintains business stability against market shocks through distribution optimization and the duplication of component suppliers, which minimizes operational disruptions. By analyzing quarterly sales margins, an investor assesses the net profit share of every dollar of revenue, determining the real efficiency of cost management and the corporation's overall financial resilience over time.

Pesaing utama

HLN: Margin dodolan resik|Rentabilitas dodolan resik KVUE|Margin resik veronapharma.com|Rentabilitas dodolan resik MENS (Jyong Biotech Corp)|Margin resik Ligand (LGND)|Margin dodolan resik amneal.com (AMRX)|Margin dodolan resik PRGO (perrigo.com)|Alvotech SA (ALVO) - Margin resik|Liquidia Inc. - Margin dodolan resik|Tingkat bathi miturut bathi resik Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Margin resik|Rentabilitas dodolan resik MNKD|Margin resik Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Margin dodolan perusahaan|Margin dodolan resik TBPH|AQST (Aquestive Therapeutics) - Tingkat bathi resik|scPharmaceuticals, Inc. - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik TECX|tonixpharma.com - Margin dodolan resik|Tingkat bathi resik SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Margin resik|Rentabilitas dodolan miturut bathi resik BioHarvest|Rentabilitas dodolan miturut bathi resik EXOZ|Rentabilitas dodolan miturut bathi resik Oramed Pharmaceuticals (ORMP)|Rentabilitas dodolan miturut bathi resik ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Rentabilitas dodolan resik|Margin dodolan resik ABVC (ABVC BioPharma Inc)|CPIX - Rentabilitas dodolan miturut bathi resik|Quantum BioPharma Corp - Margin dodolan resik|FGEN (fibrogen.com) - Rentabilitas dodolan resik|TELO (Telomir Pharmaceuticals) - Rentabilitas dodolan miturut bathi resik|Rani Therapeutics Holdings - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik SNYR|Margin resik rallybio.com RLYB|Margin dodolan resik LEXX|PULM (Pulmatrix, Inc.) - Tingkat bathi resik|Pheton Holdings - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Aptorum Group Limited APM|LYRA: Rentabilitas dodolan miturut bathi resik|IBO: Margin resik|TNFA: Margin dodolan resik|YCBD: Rentabilitas resik perusahaan|Margin resik PainReform Ltd|CYTO (altamiratherapeutics.com) - Rentabilitas resik perusahaan|Margin dodolan resik LIPO|OPTN - Margin resik|Margin resik pieris.com PIRS|Tingkat bathi resik PROC|PTPI - Margin resik|Qilian International Holding (QLI) - Rentabilitas dodolan miturut bathi resik|SLRN: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik TFF Pharma